Rothblatt Martine A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Apr 20, 2023
- Accession no.
- 0001415889-23-006756
- Filed
- Apr 20, 2023
- Trade date
- Apr 18-19, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 10 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.62M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rothblatt Martine ACIK 0001106578 | Director, Officer (CHAIRPERSON & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 18, 2023 | Common Stock | MOption exerciseAcquired | +8,000 | $113.08 | +$904,640 | 8,130 | Direct | |
| Apr 18, 2023 | Common Stock | SSaleDisposed | −4,710 | $226.37F2 | −$1,066,202.7 | 3,420 | Direct | |
| Apr 18, 2023 | Common Stock | SSaleDisposed | −2,323 | $227.10F3 | −$527,553.3 | 1,097 | Direct | |
| Apr 18, 2023 | Common Stock | SSaleDisposed | −906 | $227.96F4 | −$206,531.76 | 191 | Direct | |
| Apr 18, 2023 | Common Stock | SSaleDisposed | −61 | $229.31 | −$13,987.91 | 130 | Direct | |
| Apr 19, 2023 | Common Stock | MOption exerciseAcquired | +8,000 | $113.08 | +$904,640 | 8,130 | Direct | |
| Apr 19, 2023 | Common Stock | SSaleDisposed | −2,428 | $225.43F5 | −$547,344.04 | 5,702 | Direct | |
| Apr 19, 2023 | Common Stock | SSaleDisposed | −4,772 | $226.30F6 | −$1,079,903.6 | 930 | Direct | |
| Apr 19, 2023 | Common Stock | SSaleDisposed | −624 | $226.88F7 | −$141,573.12 | 306 | Direct | |
| Apr 19, 2023 | Common Stock | SSaleDisposed | −176 | $228.23F8 | −$40,168.48 | 130 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 18, 2023 | Common Stock | MOption exerciseDisposed | −8,000 | $0.00 | $0 | 80,000 | Direct | |
| Apr 19, 2023 | Common Stock | MOption exerciseDisposed | −8,000 | $0.00 | $0 | 72,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $225.835 to $226.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $226.855 to $227.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $227.89 to $228.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $224.735 to $225.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $225.74 to $226.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $226.75 to $227.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $228.14 to $228.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.